Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well you have crossed the most important hurdle, getting the IDIQ confirmed after Morpho complaint dismissal which implies that the TSA will use the B220 regardless of Morpho/Smiths latest non-radioactive products. So the company and stock is safe which means that until the first full production quarter April-June, CY2015Q2/FY2015Q4, is reported in the 10-K this will probably remain a trading stock around 0.8-1.2. However if hints of profitability are shown later this year the stock could go beyond that. The worst in terms of risk/fear is over for this company/stock and the pps should eventually reflect that even with DMRJ dilution. Consistent quarterly profitability is what is needed to really eat up that dilution and for the pps to rise. I suppose for existing longs it is a question of accepting your original time scales for stock appreciation have to be lengthened to fit current realities.
Stock is too illiquid for DMRJ to tie up more capital.
There are say 65 trading days in a quarter and they have an endless supply of 8c options. If the running costs of this company up to now are say $4-5m a quarter then DMRJ need to sell on average say 80K shares a day to fund this which is doable in high trading volume quarters.
I am sure DMRJ would accept a buyout as they would then get all their money in one go but I don't believe they are under any financial pressure to offload their debt before a good buyout offer materializes especially as the full IDIQ production spigots have just now been turned on with the Morpho dismissal.
DMRJ made their investment here financially self-sustaining in April 2011 when they repriced their original 26c options into 8c options which tripled the number of those options overnight.
TSMC to Start 10nm in 2017, Closing Gap with Intel
http://www.eetimes.com/document.asp?doc_id=1325787
“The performance of our 10nm, in terms of speed, power and density will be equal to what we believe Intel will define as its 10nm technology,” TSMC Director of Corporate Communications Elizabeth Sun told EE Times. “Technology-wise, we think we can close the gap at 10nm.”
Peter Greenhalgh (Director of Technology, CPU Group, ARM)
http://www.realworldtech.com/forum/?threadid=147766&curpostid=147801
'Firstly, there are micro-architectural enhancements throughout the Cortex-A72 design which improve both IPC and power. In fact, the Cortex-A72 power improvements are achieved on the same process with the same library as Cortex-A57. We aren't relying on a process shrink to achieve the power improvement or boost performance purely through frequency. Depending on the workload we're seeing anywhere between 10-50% more clock-for-clock performance than Cortex-A57 under identical system conditions while also reducing power. I'm talking about a range of decent sized, representative workloads, not micro-benchmarks.'
because it will cost less money in the long run for the long term aim of stock support/appreciation.
It's probably the company with its buyback shares. I have been posting for some time that they should defend the moving averages under the 200 MA as they contain the high volume LMT sale day and these currently peak at $2.80 i.e. 171-177 MA. The stock floats easily enough above these moving averages and this will allow consolidation and strengthening of these supporting moving averages. This is a good long term buyback strategy using TA to aid the stock price support.
DMRJ will lend more money if they required to. Why not with 60m+ 8c options in the money and production about to go to 100% capacity ? Why pull the plug now ?
No, I still agree with you that a sale is still a good possibility but I was just laying out the worst-case scenario of there being no change in the company with respect to either its ownership or creditors and how the stock would respond in that case. Any upside change therefore will be a bonus to this default no-change scenario.
Yes it's a very simple equation of supply and demand and you have far too much latent share supply for the demand of it. If the current board of directors are planning to stick with DMRJ and their virtually inexhaustible share supply then you need more demand. If you can get a string of profitable quarters going you will start getting more demand from the P/E crowd, day/swing traders, maybe even a big Institution or two. I trust McGann to generate that future demand more than that clown Bolduc but still it will be slow going and you will need even more patience if you are a true believer of this company's IP as all the major news PRs have been generated now and it will be down to performance now.
I already did, 7+ years, which is plenty of time for a $50m+ NGCD production contract in 2017 to replenish the coffers nevermind all the other streams of revenue which are all just coming online now. ASTC is not the company with the immediate threat of bankruptcy here .
Buldoc made apologies at the start of the press conference for implying the TSA was involved in it, see the replay. As for competition, as 1stDetect technology is mass-spectrometer based I never believed there was direct competition and still don't at least for the immediate future. However as the technology is tangentially related and your management/company machinations are quite a soap opera there is enough drama here to maintain my interest in your ongoing story.
No you can't see me at all because I have never had a financial interest in IMSC, either long or short, so consider my views as those of a sceptic neutral who does not like seeing shareholders of any company being taken for a ride by their management.
Indeed it was back in the spacehab days but the best astrotech year was not far off with $32m ($4.7m profit) in FY2009 / $38.1m ($8.7m profit) in CY2009 and $26m in FY2012
http://astrotechcorp.com/news-and-events/news/astrotech-reports-financial-results-for-fourth-quarter-and-fiscal-year-2009-and
http://finance.yahoo.com/q/is?s=ASTC+Income+Statement&annual
zeynoc is the one continually bringing up ASTC here for about the twentieth time purely for deflection purposes away from IMSC discussion he finds uncomfortable. I don't discuss ASTC here unless someone brings it up first.
Those days will return, this is the third successful rebirth of the company after spacehab modules and then astrotech space operations.
ASTC has made as much as $50m annual revenue, in fact there has not been one financial year in IMSC's entire existence where it has made more than ASTC and unlike IMSC ASTC has profitable quarters/years so your condescending ignorant arrogance is misplaced as always.
Only $21m has been conclusively ordered.
Fail: An IMSC PR is not straight from the TSA. IMSC have already been publicly told off once by the TSA for stretching the truth in that IDIQ conference they called.
It is a bold claim and as most of your discussion here is fantasy dream based a link to back the claim up would be nice as all I have seen in the past about the gold standard is a claim made by the discredited ex-CEO of this company who also always had great difficulty distinguishing fact from fantasy in his tenure here.
I'm not the one making the bold claim.
So none of you can back your statements up with links ?
Samsung 14nm is not a real 14nm BEOL. Geekbench3 also currently favors ARM cores with its encryption subtests. The multi-core score also uses four 2.1 GHz A57 and four 1.5 GHz A53 working at the same time which is not a sustainable configuration for any length of time. It also would be very surprising if Samsung had got its 14nm FinFETs ready for prime time production so early, let us wait and see if it is true.
You don't know the link ?
That statement was straight from the TSA in 2014.
Do you have a TSA link for that ?
I think AAPL is close to its peak. It has used its large screen joker card, what next to entice new sales before smartphone commoditization/market saturation affects it too ? Its P/E is now looking overweight at 18 and it did not go past its past year peak of 119.75 today despite 3X normal volume. It has had a fantastic run over the past decade+ but price gains look tougher now.
The NGCD prototype development project is a 2-year one up to 2016. Then the production contracts will be granted from 2017 onwards. So I don't think there will be any news for some time, however the thing to look for is more development option money up to Astrotech's complete portion of the $9.8m being booked each quarter. Only $320K has been booked so far and I think Astrotech's portion of the complete NGCD prototype development option is at least $4-5m if not more. That is how I understand it so far.
Above all moving averages, good consolidation point.
Here’s why investors are now facing another “lost decade” in the stock market
http://jessefelder.tumblr.com/post/109242478660/heres-why-investors-are-now-facing-another-lost
Fully diluted DMRJ would be the largest shareholder with all their dormant 0.08/1.09/1.18 options, they could fully dilute their stock options immediately if both they and the management were willing to do so and amended the current 5% restriction in order to carry out a subsequent corporate action. So whose side is the BoD on ?? By late March you will find out one way or the other.
the Company agreed that Mr. Bolduc shall continue to have the use of an apartment in New York City through the end of the current lease, all lease obligations of said apartment, including but not limited to rent payments and utilities, to be paid by the Company
How was this apartment ever necessary to a business based in Wilmington ? Buldoc has been living like an extravagant Roman Emperor on borrowed money (from shareholders via DMRJ) for a long time and it is no wonder this company owes over $60m where some weeks there are more sales people than sales. The rest of his golden parachute looks equally extravagant, glad most of you think it was money well spent considering McGann could have done his job easily enough from the beginning without the BS and expense.
Wake me up when IMSC has a positive book value i.e no net debt nevermind the $50m net cash that ASTC has earned through having previous profitable business. Your $162m IDIQ will not be profitable if you are selling the B220s for under $20K as all the current documentation suggests. Maybe that's why Buldoc was canned, for giving the B220s away to the TSA at a loss ?
Well it happens to be the truth, sorry you could not deal with that fact.
I feel sorry for you guys, no more or less. You deserved better leadership than a guy who could not control the company expenses, was complicit in the DMRJ shareholder rape and who misled you for years with his fantasy revenue projections and perhaps you just might get it now.
We all know who is your daddy.
LOL, ASTC is 3x this stock when it was once less than it and still rising. There are no daddies here, only you sad whiners wondering why your stock is going nowhere fast which is where I come in and explain it you as you are all so generally clueless.
Had. Both competitors IDIQs have expired now. Please try to be accurate although I know you find it very difficult.
http://www.morpho.com/detection/see-all-products/trace-detection/itemiser-r-4dx/
Using a non-radioactive ionization source and simultaneous, dual-mode detection, Itemiser® 4DX can detect a broad range of current market threat explosives and narcotics without the use of a radioactive source, thereby eliminating certification, licensing, inspection, testing and transportation costs and challenges.
The portable, ergonomic desktop unit features automated internal calibration to help decrease consumables cost, optimize ongoing equipment operation and increase detection accuracy.
http://www.morpho.com/IMG/pdf/Morpho_Itemiser_4DX.pdf
IONSCAN 600 is lighter at only 23lb and has a handle.
http://www.smithsdetection.com/index.php/products-solutions/explosives-narcotics-detection/61-explosives-narcotics-detection/ionscan-600.html
Feature highlights:
• Non-radioactive IMS source
• Easy to use interface requires minimal training
• Small, lightweight and portable
• Fully operational, hot-swappable batteries
• Cost effective swabs
The IONSCAN 600 is a next-generation, portable desktop system used to detect and identify trace amounts of explosives. It features a proprietary non-radioactive ion mobility spectrometry (IMS) source, which means licensing from national nuclear regulatory agencies is not required.
Universal software icon commands make training and operation of the IONSCAN 600 fast and easy. Onboard diagnostics also assist operators with maintenance and offer troubleshooting for error resolution.
Sampling is vastly improved and done manually with cost-effective, single-use swabs, or with an optional low-cost, redesigned wand.
The IONSCAN 600 is optimized for minimal maintenance and features a robust design to help enhance productivity.
Weighing just 23 pounds (10.4 kilograms), the IONSCAN 600 features a built-in handle that provides easy portability. Hot-swappable batteries provide sampling and analysis capability while still in use. The system also offers unmatched performance throughout extreme temperatures.
IONSCAN 600 provides accurate trace explosives detection for global aviation and critical infrastructure markets.
Detector type Non-radioactive IMS source
Sample collection Trace particle
Calibration Automatic internal self-calibration
Alarm method Substance identification with configurable audio alarm
Consumables Low cost single-use swab, verification pen
Expandability 4 USB 2.0 (2 front/2 back)
Connectivity Ethernet, Wi-Fi option, 4 USB 2.0 (standard, 2 front/2 back)
Weight 23lbs (10.43kg)
Battery 1 hour full operation, hot-swappable
Analysis time 8 seconds or less
Warm-up time Less than 10 minutes
Data display 9” high resolution, anti-reflective, color touch screen
Dimensions 14.6 x 11.4 x 12.8in (37.1 x 29.0 x 32.5cm)
Operating temperature 14 to 122°F (-10 to +50°C)
Operating altitude 13,780ft (4,200m)
Operating humidity 0 to 95% non-condensing
Explosives detection Military, commercial and HMEs (RDX, TNT, PETN, NG, AN, UN, HMTD, TATP, EGDN, Tetryl, HMX, Sulfur, TNB, DNT and others).
Narcotics detection Available 2015
Storage Capacity 50,000 samples
Printer External
Power 100-240V AC, 50-60Hz
Other Optional sampling wand, no hazardous parts, tamper proof
Seems to me Smith Detection would perhaps want to buy us so they could compete with the non-radioactive product Morpho now has.
Smiths have also introduced a non-radioactive product recently, Ionscan 600.
1) We believe the vast majority of investors with whom we speak are well aware of the issues and expect at least some of the models to be launched w/ Samsung’s own Exynos processor so the press is hardly uncovering new information; 2) our work has long suggested that QCOM was rushed and didn’t have time to customize the ARM core for 20nm for the 810 and there was an issue w/the ARM design (AAPL is already fully customized, for example, so it didn’t have this issue); 3) we believe the design issue was at the base layers – not metal as indicated by some competitors in Asia – and the resulting delay was ~2-3mos; 4) we believe QCOM already solved the issue and production for 810 is ~2-3mos behind schedule; 5) this press report speculates that Samsung will use Exynos for ALL models – we consider this UNLIKELY as Samsung would have to use a different modem and RF in addition to the SoC – this is a very big undertaking and our work suggested Samsung was not ready with a complete solution.
We shall see .